Vanda Pharmaceuticals (VNDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -39,865 | 20,186 | -21,055 | -28,617 | -9,802 |
| Depreciation Amortization | 14,231 | 2,958 | 2,082 | 2,688 | 2,864 |
| Income taxes - deferred | N/A | N/A | N/A | N/A | 1,821 |
| Accounts receivable | -12,677 | -1,623 | -863 | 450 | -1,107 |
| Accounts payable and accrued liabilities | N/A | N/A | N/A | -709 | 348 |
| Other Working Capital | 29,639 | -33,199 | -26,127 | -24,035 | -28,794 |
| Other Operating Activity | 21,121 | -69,876 | 6,371 | 5,306 | 6,260 |
| Operating Cash Flow | $12,449 | $-81,554 | $-39,592 | $-44,917 | $-28,410 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,527 | -769 | -176 | -2,017 | -275 |
| Purchase Of Investment | -193,111 | -93,343 | -65,598 | -60,866 | -160,213 |
| Sale Of Investment | 169,040 | 89,830 | 31,499 | 108,637 | 234,837 |
| Purchase Sale Intangibles | N/A | -8,000 | N/A | 0 | N/A |
| Other Investing Activity | 0 | -7,755 | 0 | 0 | -600 |
| Investing Cash Flow | $-26,598 | $-12,037 | $-34,275 | $45,754 | $73,749 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 4,374 | 90,164 | 50,055 | 12 | 25 |
| Other Financing Activity | -283 | -436 | -196 | 0 | 0 |
| Financing Cash Flow | $4,091 | $89,728 | $49,859 | $12 | $25 |
| Beginning Cash Position | 60,901 | 64,764 | 88,772 | 87,923 | 42,559 |
| End Cash Position | 50,843 | 60,901 | 64,764 | 88,772 | 87,923 |
| Net Cash Flow | $-10,058 | $-3,863 | $-24,008 | $849 | $45,364 |
| Free Cash Flow | |||||
| Operating Cash Flow | 12,449 | -81,554 | -39,592 | -44,917 | -28,410 |
| Capital Expenditure | -2,527 | -769 | -176 | -2,017 | -275 |
| Free Cash Flow | 9,922 | -82,323 | -39,768 | -46,934 | -28,685 |